Navigation Links
Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems
Date:4/1/2008

BOTHELL, Wash., April 1, 2008 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it signed a letter of intent to begin establishing Heartcentrix(R) ECG connectivity with the Misys MyWay(TM) electronic medical record (EMR) system from Misys Healthcare.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

Misys Healthcare serves more than 100,000 physicians in 18,000 practice locations. "Misys MyWay integrates EMR, practice management, and claims management to offer a simple, affordable, complete solution for physicians and clinicians," Paul Edge, Vice President, Clinical Solutions for Misys Healthcare said. "With this agreement, thousands of our customers have the potential to access information from new or currently installed Burdick and Quinton electrocardiograph (ECG) devices, stress systems, and Holter devices while using our Misys MyWay EMR systems."

The HeartCentrix solution from Cardiac Science helps bring patient history, clinical charting, e-prescribing, lab orders, results, and patient follow-up information together into a single EMR application. "We designed HeartCentrix to streamline diagnostic cardiology workflow," said Greg Newman, senior marketing manager for Cardiac Science. "Ultimately, the patient benefits. With streamlined integration, physicians have easier access to information, faster results, and fewer chances for operator error, patients receive a higher standard of care."

Tony Titus, Cardiac Science vice president of marketing added, "The agreement with Misys Hea
'/>"/>

SOURCE Cardiac Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cardiac Science Unveils Major Brand Change; Strategy to Lift Brand Awareness
2. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
3. New research shows that iPods do not interfere with cardiac pacemakers
4. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
5. Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
6. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
7. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
8. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
9. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
10. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Thomson Scientific Begins Expansion of Web of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... DIEGO , March 3, 2015  Halozyme Therapeutics, Inc. ... Barclays 2015 Global Healthcare Conference in Miami, FL ... a.m. PT. David A. Ramsay , Chief Financial Officer, ... be webcast through the "Investors" section of Halozyme,s corporate website ... available for 90 days following the event. To access the ...
(Date:3/3/2015)... and Markets ( http://www.researchandmarkets.com/research/rcv4lq/gene_therapy ) has announced ... - 2025" report to their offering. ... extensive study on the marketed and pipeline gene therapies. ... this field for over a decade but there are ... one approved in the EU). There are many promising ...
(Date:3/3/2015)... BlueInGreen announces the addition ... network. The business venture will bring the world’s ... Provinces, exclusively through Resource Systems. , Since 1986, ... premiere manufacturing representative firms, hosting a diverse portfolio ... wastewater markets. More information on Resource Systems is ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The winners ... excellence were honored by the Global Supply Chain ... which took place on Wednesday, February 25th, 2015, at ... GSCRC was formed to bring together supply chain risk ... to advance the professional discipline through opportunities to collaborate, ...
Breaking Biology Technology:Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7BlueInGreen® Continues Canadian Expansion, Partners with Resource Systems Inc. 2Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4
... ... that Maastricht based forensics lab DNalysis have successfully rolled out PatentSafe, protecting their forensic ... electronic repository. , ... Bracknell, UK (PRWEB) Feburary 10, 2010 -- Amphora Research Systems is pleased to announce ...
... , , , , , , , , , ... 12 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc.,(NYSE Amex: NBS ) ("NeoStem" ... and China , announced,today that it priced a public offering ... share. Net proceeds from the offering, after underwriting,discounts and commissions and ...
... , , ... 11 /PRNewswire-Asia/ -- 3SBio Inc. ( SSRX),("3SBio" or "the Company"), ... marketing,biopharmaceutical products, today announced its unaudited financial results,for the fourth quarter and ... Full Year 2009 Financial Highlights:, -- Total net ...
Cached Biology Technology:Independent Forensics Company DNalysis Implement Amphora's PatentSafe Solution to Preserve and Secure Findings 2Independent Forensics Company DNalysis Implement Amphora's PatentSafe Solution to Preserve and Secure Findings 3NeoStem Prices Public Offering of 5,000,000 Shares of Common Stock 2NeoStem Prices Public Offering of 5,000,000 Shares of Common Stock 3NeoStem Prices Public Offering of 5,000,000 Shares of Common Stock 43SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 23SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 33SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 43SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 53SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 63SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 73SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 83SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 93SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 103SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 113SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 123SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 133SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 143SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 153SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 163SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 173SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 183SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 193SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 203SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 213SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 223SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 233SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 243SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 253SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 26
(Date:2/5/2015)... 2015   Epic Sciences , a precision diagnostics company ... Murali Prahalad , Ph.D., president and CEO, is scheduled ... (PMWC) 2015: Silicon Valley, which is taking place at the ... on January 26-28, 2015. Dr. Prahalad ... Biomarkers." Last year, Epic Sciences was a finalist in the ...
(Date:2/5/2015)... , Jan. 27, 2015   ... of globally deployed, innovative test solutions for ... the delivery of its TS-323 GENASYS ... Systems Company (LMSSC). GENASYS is a high-performance ... of mission-critical applications that require performance functional ...
(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... protecting us from diseases, but how does it do ... before dendritic cells move to the lymph nodes they ... much faster. Immature dendritic cells patrol the tissues in ... undergo a rigorous maturation process. During this maturation the ...
... St. Jude Children,s Research Hospital have discovered that a ... its identity that it requires the constant expression of ... The researchers showed that Prox1 acts as a two-way ... type of cell, called a lymphatic endothelial cell (LEC). ...
... of propensities acquired in the womb) reveals that consuming ... may significantly affect breast cancer outcomes for a mother,s ... Boston University is the first to link choline consumption ... first to identify possible choline-related genetic changes that affect ...
Cached Biology News:Immune cells reveal fancy footwork 2Reprogrammable cell type depends on a single gene to keep its identity 2Eating eggs when pregnant affects breast cancer in offspring 2
Rat Antibody to Mouse TCR VB8.1,8.2:FITC Recognises the V beta 8.1 and V beta 8.2 determinants of the murine T cell receptor. Specificity: mouse TCR VB8.1 and 8.2...
fli-1...
Vesicle Associated Membrane Protein (VAMP 1/2)...
Anti-Mouse Valpha 2 TCR, Purified (Clone B20.1) (rat IgG2a)...
Biology Products: